Release Date: 30/10/12 18:29 Summary: Quarterly Activities Report and Appendix 5B Price Sensitive: Yes Download Document 869.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%